IGMPI facebook Clinical Research
IGMPI Logo
Faculty of Clinical Research and Drug Safety

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Competency based placement focussed Education I Training I Research I Consultancy

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular | Part-time (Online Live Classes) Modes

Clinical Research

Eli Lilly declares positive data from Phase III HFpEF treatment trial
PepGen declares positive data from Phase II trial of Duchenne muscular dystrophy
AstraZeneca declares positive data from chronic lymphocytic leukaemia therapy trial
Natera showcases positive results for Merkel cell carcinoma surveillance test
Phase IIa Alzheimer’s therapy trial meets primary efficacy endpoints : Longeveron
Ultimovacs cancer vaccine fails to meet endpoints in Phase II trial for head and neck cancer
Aldeyra’s Reproxalap meets primary endpoint in Phase III clinical trial
Sobi and Apellis exhibit positive topline outcomes from Phase III pegcetacoplan study
AN2 reduced its headcount by 50% after lead antibiotic fails in Phase II/III trial
Leo Pharma?s Timber reported Phase III failure
PainReform documents safety information from Phase III bunionectomy trial of PRF-110
Innovo announces data from Phase II post-thyroidectomy scar treatment trial
Discontinued two Phase III Keytruda trials: MSD
Neurocrine announces positive data from Phase II schizophrenia treatment trial
Phase III trial of Leqvio in ASCVD patients meets key primary endpoints : Novartis